Calidi Biotherapeutics (CLDI) Earnings Date & Reports
A.I. Advisor
published Earnings
CLDI is expected to report earnings to fall 86.43% to -18 cents per share on November 13
Q3'24
Est.
$-0.19
Q2'24
Missed
by $1.21
Q1'24
Beat
by $0.08
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.03
The last earnings report on August 14 showed earnings per share of -139 cents, missing the estimate of -18 cents. With 93.82K shares outstanding, the current market capitalization sits at 9.78M.